191 related articles for article (PubMed ID: 22644217)
1. [Guideline for the prevention and early detection of breast and ovarian cancer in high risk patients, particularly in women from HBOC (hereditary breast and ovarian cancer) families].
Singer CF; Tea MK; Pristauz G; Hubalek M; Rappaport C; Riedl C; Helbich T
Wien Klin Wochenschr; 2012 May; 124(9-10):334-9. PubMed ID: 22644217
[TBL] [Abstract][Full Text] [Related]
2. AGO Austria recommendations for genetic testing of patients with ovarian cancer.
Marth C; Hubalek M; Petru E; Polterauer S; Reinthaller A; Schauer C; Scholl-Firon T; Singer CF; Zschocke J; Zeimet AG
Wien Klin Wochenschr; 2015 Aug; 127(15-16):652-4. PubMed ID: 26109557
[TBL] [Abstract][Full Text] [Related]
3. Clinical Practice Guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families.
Singer CF; Tea MK; Pristauz G; Hubalek M; Rappaport C; Riedl CC; Helbich TH
Wien Klin Wochenschr; 2015 Dec; 127(23-24):981-6. PubMed ID: 26525377
[TBL] [Abstract][Full Text] [Related]
4. Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines.
Beckmann MW; Schnürch HG; Bodden-Heidrich R; Mosny DS; Crombach G; Nitz U; Achnoula M; Bender HG
Eur J Cancer Prev; 1996 Dec; 5(6):468-75. PubMed ID: 9061278
[TBL] [Abstract][Full Text] [Related]
5. Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care.
Head M; Cohn B; Wernli KJ; Palazzo L; Ehrlich K; Matson A; Knerr S
Womens Health Issues; 2024; 34(3):268-275. PubMed ID: 38448251
[TBL] [Abstract][Full Text] [Related]
6. EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer.
McDevitt T; Durkie M; Arnold N; Burghel GJ; Butler S; Claes KBM; Logan P; Robinson R; Sheils K; Wolstenholme N; Hanson H; Turnbull C; Hume S
Eur J Hum Genet; 2024 May; 32(5):479-488. PubMed ID: 38443545
[TBL] [Abstract][Full Text] [Related]
7. The Japanese Breast Cancer Society clinical practice guideline for epidemiology and prevention of breast cancer.
Taira N; Arai M; Ikeda M; Iwasaki M; Okamura H; Takamatsu K; Yamamoto S; Ohsumi S; Mukai H;
Breast Cancer; 2015 Jan; 22(1):16-27. PubMed ID: 25085807
[No Abstract] [Full Text] [Related]
8. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A
J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
[TBL] [Abstract][Full Text] [Related]
9. SEOM clinical guidelines in hereditary breast and ovarian cancer (2019).
González-Santiago S; Ramón Y Cajal T; Aguirre E; Alés-Martínez JE; Andrés R; Balmaña J; Graña B; Herrero A; Llort G; González-Del-Alba A;
Clin Transl Oncol; 2020 Feb; 22(2):193-200. PubMed ID: 31889241
[TBL] [Abstract][Full Text] [Related]
10. Reply to the Letter to the Editor 'There is no place for ovarian cancer screening in hereditary breast-ovarian cancer syndromes (in regard to "ESMO Clinical Practice Guideline on risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes")' by W. Tjalma.
Sessa C; Paluch-Shimon S;
Ann Oncol; 2024 Jan; 35(1):139-140. PubMed ID: 37898238
[No Abstract] [Full Text] [Related]
11. [Recommendations for treatment of individuals at risk for hereditary breast and ovarian carcinoma].
Radulović S; Branković-Magić M; Janković R; Ristanović M
Srp Arh Celok Lek; 2003; 131(7-8):345-50. PubMed ID: 14692152
[TBL] [Abstract][Full Text] [Related]
12. Identification of women at risk of hereditary breast-ovarian cancer among participants in a population-based breast cancer screening.
Bonelli L; Valle I; Rebora I; Ricci P; Biocchi L; Bruschi G; Parodi S; Bruzzone C; Varesco L
Fam Cancer; 2022 Jul; 21(3):309-318. PubMed ID: 34669096
[TBL] [Abstract][Full Text] [Related]
13. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline.
Sessa C; Balmaña J; Bober SL; Cardoso MJ; Colombo N; Curigliano G; Domchek SM; Evans DG; Fischerova D; Harbeck N; Kuhl C; Lemley B; Levy-Lahad E; Lambertini M; Ledermann JA; Loibl S; Phillips KA; Paluch-Shimon S;
Ann Oncol; 2023 Jan; 34(1):33-47. PubMed ID: 36307055
[No Abstract] [Full Text] [Related]
14. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
[TBL] [Abstract][Full Text] [Related]
15. Cancer surveillance behaviors in women presenting for clinical BRCA genetic susceptibility testing.
Loescher LJ; Lim KH; Leitner O; Ray J; D'Souza J; Armstrong CM
Oncol Nurs Forum; 2009 Mar; 36(2):E57-67. PubMed ID: 19273395
[TBL] [Abstract][Full Text] [Related]
16. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.
Paluch-Shimon S; Cardoso F; Sessa C; Balmana J; Cardoso MJ; Gilbert F; Senkus E;
Ann Oncol; 2016 Sep; 27(suppl 5):v103-v110. PubMed ID: 27664246
[No Abstract] [Full Text] [Related]
17. Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening.
Smith RA; Andrews KS; Brooks D; Fedewa SA; Manassaram-Baptiste D; Saslow D; Brawley OW; Wender RC
CA Cancer J Clin; 2017 Mar; 67(2):100-121. PubMed ID: 28170086
[TBL] [Abstract][Full Text] [Related]
18. Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting.
Morgan D; Sylvester H; Lucas FL; Miesfeldt S
Fam Cancer; 2009; 8(4):277-87. PubMed ID: 19347608
[TBL] [Abstract][Full Text] [Related]
19. Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.
Robson ME
Cancer Control; 2002; 9(6):457-65. PubMed ID: 12514563
[TBL] [Abstract][Full Text] [Related]
20. Hereditary Breast and Ovarian Cancer Screening Syndrome Profile in Women Diagnosed with Breast Cancer from Paraná State Southwest.
Moura JB; Ghedin CC; Takakura ÉT; Scandolara TB; Rech D; Panis C
Rev Bras Ginecol Obstet; 2021 Aug; 43(8):616-621. PubMed ID: 34547796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
